Biotricity Stock Based Compensation vs Change Receivables Analysis
BTCY Stock | USD 1.19 0.02 1.65% |
Biotricity financial indicator trend analysis is way more than just evaluating Biotricity prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biotricity is a good investment. Please check the relationship between Biotricity Stock Based Compensation and its Change Receivables accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.
Stock Based Compensation vs Change Receivables
Stock Based Compensation vs Change Receivables Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biotricity Stock Based Compensation account and Change Receivables. At this time, the significance of the direction appears to have no relationship.
The correlation between Biotricity's Stock Based Compensation and Change Receivables is 0.04. Overlapping area represents the amount of variation of Stock Based Compensation that can explain the historical movement of Change Receivables in the same time period over historical financial statements of Biotricity, assuming nothing else is changed. The correlation between historical values of Biotricity's Stock Based Compensation and Change Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Stock Based Compensation of Biotricity are associated (or correlated) with its Change Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change Receivables has no effect on the direction of Stock Based Compensation i.e., Biotricity's Stock Based Compensation and Change Receivables go up and down completely randomly.
Correlation Coefficient | 0.04 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Change Receivables
The difference in the amount of accounts receivable from one accounting period to the next. A positive number indicates an increase in receivables, while a negative number indicates a decrease.Most indicators from Biotricity's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biotricity current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.At this time, Biotricity's Selling General Administrative is fairly stable compared to the past year. Enterprise Value is likely to rise to about 11.4 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 2.2 M in 2024.
Biotricity fundamental ratios Correlations
Click cells to compare fundamentals
Biotricity Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Biotricity fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 2.0M | 4.4M | 16.7M | 6.5M | 7.5M | 7.9M | |
Short Long Term Debt Total | 2.3M | 4.7M | 15.4M | 19.5M | 22.5M | 23.6M | |
Other Current Liab | 427.6K | 3.6M | 520.7K | 1.0M | 1.2M | 977.3K | |
Total Current Liabilities | 3.8M | 10.5M | 4.9M | 11.2M | 12.8M | 13.5M | |
Total Stockholder Equity | (3.0M) | (6.8M) | (2.1M) | (19.8M) | (17.9M) | (17.0M) | |
Net Debt | 1.4M | 2.5M | 3.3M | 19.0M | 21.8M | 22.9M | |
Retained Earnings | (46.4M) | (62.8M) | (93.0M) | (112.6M) | (101.3M) | (96.2M) | |
Accounts Payable | 1.1M | 1.0M | 1.2M | 3.4M | 4.0M | 4.1M | |
Cash | 949.8K | 2.2M | 12.1M | 570.5K | 656.0K | 623.2K | |
Cash And Short Term Investments | 949.8K | 2.2M | 12.1M | 570.5K | 656.0K | 623.2K | |
Net Receivables | 623.3K | 1.8M | 2.4M | 1.8M | 2.1M | 2.2M | |
Common Stock Total Equity | 31.9K | 35.4K | 36.4K | 39.0K | 44.9K | 27.8K | |
Common Stock Shares Outstanding | 6.0M | 6.3M | 7.6M | 8.7M | 10.0M | 7.3M | |
Liabilities And Stockholders Equity | 2.0M | 4.4M | 16.7M | 6.5M | 7.5M | 7.9M | |
Non Current Liabilities Total | 1.2M | 780.9K | 14.0M | 15.2M | 17.5M | 18.3M | |
Other Stockholder Equity | 44.2M | 56.6M | 91.6M | 92.8M | 106.7M | 112.1M | |
Total Liab | 5.0M | 11.3M | 18.8M | 26.4M | 30.3M | 31.8M | |
Total Current Assets | 1.7M | 4.3M | 15.3M | 4.7M | 5.4M | 3.2M | |
Accumulated Other Comprehensive Income | (857.3K) | (634.2K) | (768.7K) | (152.8K) | (137.5K) | (144.4K) | |
Short Term Debt | 2.3M | 4.3M | 1.8M | 5.1M | 5.9M | 6.2M | |
Common Stock | 36.4K | 39.0K | 51.3K | 52.5K | 60.4K | 33.8K | |
Net Tangible Assets | (1.8M) | (3.0M) | (6.8M) | (2.1M) | (1.9M) | (2.0M) | |
Non Current Assets Total | 345.6K | 116.5K | 1.4M | 1.8M | 2.1M | 2.2M | |
Short Term Investments | 137.1K | 326.7K | 302.3K | 588.6K | 676.9K | 710.7K | |
Inventory | 85.7K | 272.5K | 842.9K | 2.3M | 2.7M | 2.8M | |
Other Current Assets | 137.1K | 326.7K | 406.3K | 588.6K | 676.9K | 710.7K | |
Short Long Term Debt | 2.1M | 4.3M | 1.5M | 4.8M | 5.5M | 5.8M | |
Net Invested Capital | (932.1K) | (2.2M) | 11.9M | (2.0M) | (2.3M) | (2.2M) | |
Net Working Capital | (2.1M) | (6.2M) | 10.5M | (6.4M) | (5.8M) | (5.5M) | |
Capital Stock | 36.4K | 39.0K | 51.3K | 52.5K | 60.4K | 47.2K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Biotricity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biotricity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biotricity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biotricity Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.Note that the Biotricity information on this page should be used as a complementary analysis to other Biotricity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Biotricity Stock analysis
When running Biotricity's price analysis, check to measure Biotricity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotricity is operating at the current time. Most of Biotricity's value examination focuses on studying past and present price action to predict the probability of Biotricity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotricity's price. Additionally, you may evaluate how the addition of Biotricity to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is Biotricity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biotricity. If investors know Biotricity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biotricity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.75) | Revenue Per Share 1.319 | Quarterly Revenue Growth 0.209 | Return On Assets (0.95) | Return On Equity (41.01) |
The market value of Biotricity is measured differently than its book value, which is the value of Biotricity that is recorded on the company's balance sheet. Investors also form their own opinion of Biotricity's value that differs from its market value or its book value, called intrinsic value, which is Biotricity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biotricity's market value can be influenced by many factors that don't directly affect Biotricity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biotricity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotricity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotricity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.